CMPI Insider Transactions
| Transaction Date (SEC Report) |
Reporting Name | Relationship | Shrs. Owned | Type | Acq./Disp. | Shrs. Transacted | Price() | Amount() |
|---|---|---|---|---|---|---|---|---|
| 2022-05-31 | POWELL MICHAEL | director | 0 | D-Return | D | 30,000 | 5.19 | 155,700.00 |
| 2022-05-31 | POWELL MICHAEL | director | 0 | D-Return | D | 10,030 | 6.27 | 62,888.00 |
| 2022-05-31 | POWELL MICHAEL | director | 0 | D-Return | D | 30,000 | 10.95 | 328,500.00 |
| 2022-05-31 | Flaherty Keith T. | director | 0 | D-Return | D | 10,030 | 6.27 | 62,888.00 |
| 2022-05-31 | Flaherty Keith T. | director | 0 | D-Return | D | 4,012 | 2.47 | 9,910.00 |
| 2022-05-31 | Flaherty Keith T. | director | 0 | D-Return | D | 22,736 | 2.62 | 59,568.00 |
| 2022-05-31 | Isacoff Oren | director | 0 | D-Return | D | 10,030 | 6.27 | 62,888.00 |
| 2022-05-31 | Isacoff Oren | director | 0 | D-Return | D | 20,000 | 10.95 | 219,000.00 |
| 2022-05-31 | Wigginton Jon Marc | director | 0 | D-Return | D | 20,061 | 2.19 | 43,934.00 |
| 2022-05-31 | Fuhrman Alan | director | 0 | D-Return | D | 246,671 | 3.93 | 969,417.00 |
| 2022-05-31 | Fuhrman Alan | director | 0 | D-Return | D | 10,030 | 6.27 | 62,888.00 |
| 2022-05-31 | Fuhrman Alan | director | 0 | D-Return | D | 22,736 | 2.62 | 59,568.00 |
| 2022-05-13 | venBio Global Strategic Fund II L.P. | 10 percent owner | 2,251,730 | S-Sale | D | 35,850 | 10.45 | 374,464.00 |
| 2022-05-16 | venBio Global Strategic Fund II L.P. | 10 percent owner | 2,155,930 | S-Sale | D | 95,800 | 10.45 | 1,001,100.00 |
| 2022-05-10 | venBio Global Strategic Fund II L.P. | 10 percent owner | 2,429,805 | S-Sale | D | 18,676 | 10.38 | 193,870.00 |
| 2022-05-11 | venBio Global Strategic Fund II L.P. | 10 percent owner | 2,412,105 | S-Sale | D | 17,700 | 10.38 | 183,641.00 |
| 2022-05-12 | venBio Global Strategic Fund II L.P. | 10 percent owner | 2,287,580 | S-Sale | D | 124,525 | 10.39 | 1,294,313.00 |
| 2022-05-05 | venBio Global Strategic Fund II L.P. | 10 percent owner | 2,514,415 | S-Sale | D | 20,743 | 10.37 | 215,105.00 |
| 2022-05-06 | venBio Global Strategic Fund II L.P. | 10 percent owner | 2,466,081 | S-Sale | D | 48,334 | 10.37 | 501,233.00 |
| 2022-05-09 | venBio Global Strategic Fund II L.P. | 10 percent owner | 2,448,481 | S-Sale | D | 17,600 | 10.37 | 182,582.00 |
| 2022-05-02 | venBio Global Strategic Fund II L.P. | 10 percent owner | 2,652,133 | S-Sale | D | 153,700 | 10.38 | 1,595,975.00 |
| 2022-05-03 | venBio Global Strategic Fund II L.P. | 10 percent owner | 2,572,658 | S-Sale | D | 79,475 | 10.37 | 824,434.00 |
| 2022-05-04 | venBio Global Strategic Fund II L.P. | 10 percent owner | 2,535,158 | S-Sale | D | 37,500 | 10.37 | 388,924.00 |
| 2022-04-27 | venBio Global Strategic Fund II L.P. | 10 percent owner | 2,948,463 | S-Sale | D | 47,396 | 10.38 | 491,980.00 |
| 2022-04-28 | venBio Global Strategic Fund II L.P. | 10 percent owner | 2,875,063 | S-Sale | D | 73,400 | 10.38 | 761,936.00 |
| 2022-04-29 | venBio Global Strategic Fund II L.P. | 10 percent owner | 2,805,833 | S-Sale | D | 69,230 | 10.38 | 718,663.00 |
| 2022-04-22 | venBio Global Strategic Fund II L.P. | 10 percent owner | 3,088,210 | S-Sale | D | 37,430 | 10.39 | 388,834.00 |
| 2022-04-25 | venBio Global Strategic Fund II L.P. | 10 percent owner | 3,060,542 | S-Sale | D | 27,668 | 10.39 | 287,404.00 |
| 2022-04-26 | venBio Global Strategic Fund II L.P. | 10 percent owner | 2,995,859 | S-Sale | D | 64,683 | 10.38 | 671,558.00 |
| 2022-04-19 | venBio Global Strategic Fund II L.P. | 10 percent owner | 3,273,451 | S-Sale | D | 399,923 | 10.42 | 4,165,238.00 |
| 2022-04-20 | venBio Global Strategic Fund II L.P. | 10 percent owner | 3,187,840 | S-Sale | D | 85,611 | 10.39 | 889,387.00 |
| 2022-04-21 | venBio Global Strategic Fund II L.P. | 10 percent owner | 3,125,640 | S-Sale | D | 62,200 | 10.38 | 645,866.00 |
| 2022-02-23 | Novo Holdings A/S | 10 percent owner | 2,168,280 | S-Sale | D | 1,820 | 2.90 | 5,277.00 |
| 2022-02-24 | Novo Holdings A/S | 10 percent owner | 2,162,290 | S-Sale | D | 5,990 | 2.83 | 16,979.00 |
| 2022-02-25 | Novo Holdings A/S | 10 percent owner | 2,161,990 | S-Sale | D | 300 | 2.70 | 811.00 |
| 2022-01-30 | Wigginton Jon Marc | director | 20,061 | A-Award | A | 20,061 | 2.19 | 43,934.00 |
| 2022-01-30 | Wigginton Jon Marc | director: | 0 | 0 | 0.00 | 0.00 | ||
| 2021-10-27 | Fuhrman Alan | director, officer: See Remarks | 246,671 | A-Award | A | 246,671 | 3.93 | 969,417.00 |
| 2021-08-09 | POWELL MICHAEL | director | 30,000 | A-Award | A | 30,000 | 5.19 | 155,700.00 |
| 2021-08-04 | Chaudhary Kleem | officer: Chief Business Officer | 27,300 | A-Award | A | 27,300 | 5.09 | 138,957.00 |
| 2021-06-16 | Flaherty Keith T. | director | 10,030 | A-Award | A | 10,030 | 6.27 | 62,888.00 |
| 2021-06-16 | Fuhrman Alan | director | 10,030 | A-Award | A | 10,030 | 6.27 | 62,888.00 |
| 2021-06-16 | Isacoff Oren | director | 10,030 | A-Award | A | 10,030 | 6.27 | 62,888.00 |
| 2021-06-16 | POWELL MICHAEL | director | 10,030 | A-Award | A | 10,030 | 6.27 | 62,888.00 |
| 2021-06-18 | Krieg Arthur M | officer: Chief Scientific Officer | 815,734 | P-Purchase | A | 7,224 | 6.04 | 43,633.00 |
| 2021-06-16 | Krieg Arthur M | officer: Chief Scientific Officer | 808,510 | P-Purchase | A | 3,578 | 6.18 | 22,112.00 |
| 2021-05-28 | Krieg Arthur M | officer: Chief Scientific Officer | 0 | J-Other | D | 68,457 | 0.00 | 0.00 |
| 2021-05-18 | Krieg Arthur M | officer: Chief Scientific Officer | 804,932 | P-Purchase | A | 25,001 | 6.97 | 174,257.00 |
| 2021-03-29 | Krieg Arthur M | officer: Chief Scientific Officer | 779,931 | P-Purchase | A | 15,752 | 11.40 | 179,573.00 |
| 2021-03-29 | Krieg Arthur M | officer: Chief Scientific Officer | 764,179 | P-Purchase | A | 17,468 | 10.94 | 191,100.00 |
| 2021-03-26 | Krieg Arthur M | officer: Chief Scientific Officer | 746,711 | P-Purchase | A | 3,484 | 12.15 | 42,331.00 |
| 2021-03-25 | Krieg Arthur M | officer: Chief Scientific Officer | 743,227 | P-Purchase | A | 10,036 | 12.35 | 123,945.00 |
| 2021-02-26 | Chaudhary Kleem | officer: Chief Business Officer | 97,508 | M-Exempt | D | 2,000 | 2.62 | 5,240.00 |
| 2021-02-26 | Chaudhary Kleem | officer: Chief Business Officer | 8,000 | M-Exempt | A | 2,000 | 2.62 | 5,240.00 |
| 2021-01-27 | Krieg Arthur M | officer: Chief Scientific Officer | 733,191 | P-Purchase | A | 1,701 | 13.05 | 22,198.00 |
| 2021-01-19 | Krieg Arthur M | officer: Chief Scientific Officer | 731,490 | P-Purchase | A | 500 | 13.09 | 6,545.00 |
| 2021-01-14 | Chaudhary Kleem | officer: Chief Business Officer | 99,508 | M-Exempt | D | 2,000 | 2.62 | 5,240.00 |
| 2021-01-14 | Chaudhary Kleem | officer: Chief Business Officer | 6,000 | M-Exempt | A | 2,000 | 2.62 | 5,240.00 |
| 2020-12-29 | Krieg Arthur M | officer: Chief Scientific Officer | 730,990 | P-Purchase | A | 443 | 14.16 | 6,273.00 |
| 2020-12-22 | Chaudhary Kleem | officer: Chief Business Officer | 101,508 | M-Exempt | D | 4,000 | 2.62 | 10,480.00 |
| 2020-12-22 | Chaudhary Kleem | officer: Chief Business Officer | 4,000 | M-Exempt | A | 4,000 | 2.62 | 10,480.00 |
| 2020-12-22 | Krieg Arthur M | officer: Chief Scientific Officer | 730,547 | P-Purchase | A | 5,103 | 14.64 | 74,708.00 |
| 2020-12-16 | Krieg Arthur M | officer: Chief Scientific Officer | 725,444 | P-Purchase | A | 4,805 | 14.62 | 70,249.00 |
| 2020-12-15 | Krieg Arthur M | officer: Chief Scientific Officer | 720,639 | P-Purchase | A | 42 | 14.49 | 608.60 |
| 2020-11-10 | POWELL MICHAEL | director, 10 percent owner: | 30,000 | A-Award | A | 30,000 | 10.95 | 328,500.00 |
| 2020-11-10 | Isacoff Oren | director | 20,000 | A-Award | A | 20,000 | 10.95 | 219,000.00 |
| 2020-08-11 | Novo Holdings A/S | 10 percent owner | 2,170,100 | P-Purchase | A | 500,000 | 15.00 | 7,500,000.00 |
| 2020-08-11 | Novo Holdings A/S | 10 percent owner | 1,670,100 | C-Conversion | A | 1,670,100 | 0.00 | 0.00 |
| 2020-08-11 | Novo Holdings A/S | 10 percent owner | 0 | C-Conversion | D | 12,487,512 | 0.00 | 0.00 |
| 2020-08-11 | POWELL MICHAEL | director, 10 percent owner: | 3,606,707 | P-Purchase | A | 133,333 | 15.00 | 1,999,995.00 |
| 2020-08-11 | POWELL MICHAEL | director, 10 percent owner: | 3,473,374 | C-Conversion | A | 3,473,374 | 0.00 | 0.00 |
| 2020-08-11 | POWELL MICHAEL | director, 10 percent owner: | 0 | C-Conversion | D | 8,753,350 | 0.00 | 0.00 |
| 2020-08-11 | POWELL MICHAEL | director, 10 percent owner: | 0 | C-Conversion | D | 12,500,000 | 0.00 | 0.00 |
| 2020-08-11 | POWELL MICHAEL | director, 10 percent owner: | 0 | C-Conversion | D | 3,644,624 | 0.00 | 0.00 |
| 2020-08-11 | venBio Global Strategic Fund II L.P. | 10 percent owner | 3,673,374 | P-Purchase | A | 200,000 | 15.00 | 3,000,000.00 |
| 2020-08-11 | venBio Global Strategic Fund II L.P. | 10 percent owner | 3,473,374 | C-Conversion | A | 3,473,374 | 0.00 | 0.00 |
| 2020-08-11 | venBio Global Strategic Fund II L.P. | 10 percent owner | 0 | C-Conversion | D | 12,500,000 | 0.00 | 0.00 |
| 2020-08-11 | venBio Global Strategic Fund II L.P. | 10 percent owner | 0 | C-Conversion | D | 8,753,350 | 0.00 | 0.00 |
| 2020-08-11 | venBio Global Strategic Fund II L.P. | 10 percent owner | 0 | C-Conversion | D | 3,644,624 | 0.00 | 0.00 |
| 2020-08-06 | Brennan Karen | officer: Chief Operating Officer | 53,496 | A-Award | A | 53,496 | 15.00 | 802,440.00 |
| 2020-08-06 | Chaudhary Kleem | officer: Chief Business Officer | 141,226 | A-Award | A | 141,226 | 15.00 | 2,118,390.00 |
| 2020-08-06 | Krieg Arthur M | director, officer: Chief Scientific Officer | 720,597 | D | 0 | 0.00 | 0.00 | |
| 2020-08-06 | Krieg Arthur M | director, officer: Chief Scientific Officer | 68,457 | I | 0 | 0.00 | 0.00 | |
| 2020-08-06 | Isacoff Oren | director: | 0 | 0 | 0.00 | 0.00 | ||
| 2020-08-06 | POWELL MICHAEL | director, 10 percent owner: | 0 | I | 1,671,771 | 0.00 | 0.00 | |
| 2020-08-06 | POWELL MICHAEL | director, 10 percent owner: | 0 | I | 1,314,165 | 0.00 | 0.00 | |
| 2020-08-06 | POWELL MICHAEL | director, 10 percent owner: | 0 | I | 487,438 | 0.00 | 0.00 | |
| 2020-08-06 | Chaudhary Kleem | officer: Chief Business Officer | 0 | D | 105,508 | 2.62 | 276,431.00 | |
| 2020-08-06 | Fuhrman Alan | director | 0 | D | 22,736 | 2.62 | 59,568.00 | |
| 2020-03-27 | Flaherty Keith T. | director | 0 | D | 4,012 | 2.47 | 9,910.00 | |
| 2020-08-06 | Flaherty Keith T. | director | 0 | D | 22,736 | 2.62 | 59,568.00 | |
| 2020-08-06 | Lieber Jonathan I | officer | 0 | 0 | 0.00 | 0.00 | ||
| 2020-08-06 | Brennan Karen | officer: Chief Operating Officer | 0 | D | 72,153 | 2.47 | 178,218.00 | |
| 2020-08-06 | venBio Global Strategic Fund II L.P. | 10 percent owner | 0 | D | 1,671,771 | 0.00 | 0.00 | |
| 2020-08-06 | venBio Global Strategic Fund II L.P. | 10 percent owner | 0 | D | 1,314,165 | 0.00 | 0.00 | |
| 2020-08-06 | venBio Global Strategic Fund II L.P. | 10 percent owner | 0 | D | 487,438 | 0.00 | 0.00 | |
| 2020-08-06 | Novo Holdings A/S | 10 percent owner | 0 | D | 1,670,100 | 0.00 | 0.00 |
Disclaimer: The data contained in this website is not necessarily real-time nor accurate. All derived (stocks, indexes, futures) and Forex prices are not provided by exchanges but rather by our third party API www.financialmodellingprep.com, and so prices may not be accurate and may differ from the actual market price, meaning prices are indicative and not appropriate for trading purposes. Therefore, Discounting Cash Flows Inc. doesn't bear any responsibility for any trading losses you might incur as a result of using this data. Discounting Cash Flows Inc. or anyone involved with Discounting Cash Flows Inc. will not accept any liability for loss or damage as a result of reliance on the information including data, quotes, charts and buy/sell signals contained within this website. Please be fully informed regarding the risks and costs associated with trading the financial markets, it is one of the riskiest investment forms possible.
